Abstract 18149: Soluble Guanylate Cyclase-α1 in Bone Marrow Derived Cells is Required for Inhaled Nitric Oxide to Improve Outcomes After Cardiac Arrest and Cardiopulmonary Resuscitation in Mice

Kei Hayashida,Kohei Ikeda,Eizo Marutani,Aurora Magliocca,Naohiro Mori,Robert E. Tainsh,Kimberly B. Johansson,David K. Rhee,Emmanuel S. Buys,Fumito Ichinose

Abstract 18149: Soluble Guanylate Cyclase-α1 in Bone Marrow Derived Cells is Required for Inhaled Nitric Oxide to Improve Outcomes After Cardiac Arrest and Cardiopulmonary Resuscitation in Mice

2017

Kei Hayashida
Kohei Ikeda
Eizo Marutani
Aurora Magliocca
Naohiro Mori
Robert E. Tainsh
Kimberly B. Johansson
David K. Rhee
Emmanuel S. Buys
Fumito Ichinose

Objective: Inhaled nitric oxide (iNO) improved outcomes after cardiac arrest (CA) and CPR via a soluble guanylate cyclase α1 (sGCα1)-dependent mechanism in mice. However, mechanisms responsible for...

Keywords:

Cardiopulmonary resuscitation
Nitric oxide
Bone marrow
Pharmacology
Diabetes mellitus
Internal medicine
Cardiology
Guanylate cyclase
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations